ALTITUDE: defining a ceiling for blockade of the renin-angiotensin system?

Lancet Diabetes Endocrinol. 2016 Apr;4(4):289-90. doi: 10.1016/S2213-8587(15)00518-5. Epub 2016 Jan 14.

Authors

Martin Gallagher¹, Muh Geot Wong², Vlado Perkovic²

Affiliations

¹ The George Institute for Global Health, University of Sydney, Sydney 2050, NSW, Australia; Concord Hospital, Sydney, NSW, Australia. Electronic address: mgallagher@georgeinstitute.org.au.
² The George Institute for Global Health, University of Sydney, Sydney 2050, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia.

PMID: 26774607
DOI: 10.1016/S2213-8587(15)00518-5

No abstract available

Publication types

Comment

MeSH terms

Altitude*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Humans
Renin
Renin-Angiotensin System*

Substances

Angiotensin-Converting Enzyme Inhibitors
Renin